Merck: This Cancer-Drug Powerhouse Could Be a Core Dividend
A dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Understanding when to pay capital gains on airdrops helps you align reporting with disposition events and IRS rules in 2026.
26,521 articlesA dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
MBA data through Q3 2025 show a persistent profitability split among lenders, with top-tier banks earning far more pe...
When volatility strikes in crypto markets, savvy treasury moves can reshape investor value. This piece examines how a...
Sunrun’s Thursday rally followed a robust first-quarter report, highlighting strong revenue growth and a surge in ene...
Investors eye the long end of the curve as Kevin Warsh's QT stance shifts income dynamics. Forget utility dividends. ...
Salesforce’s AI roadmap has captivated many, but the stock has faced a steep pullback. This article weighs the bulls’...
SpaceX publicly reframes its business as AI services and infrastructure, a move that could redefine growth prospects ...
Investors are weighing Tilray and Trulieve to find the better marijuana stock right now. This guide breaks down funda...
On June 17, US spot Bitcoin ETFs flipped to net red, with total outflows of $82.2 million. The day highlighted a clea...
JPMorgan Chase named Doug Petno and Troy Rohrbaugh as co-presidents, effective immediately, as the board advances its...
Binance unveiled a sweeping move into the Philippines under a regulatory sandbox, a move critics say banks on Asia gr...
Tesla just posted its strongest quarter in years, with a delivery beat powered by Model 3 and Model Y. This deep dive...